Michigan Institute of Urology

What Michigan Institute of Urology does

Michigan Institute of Urology (MIU), P.C. is an independent, physician-owned professional corporation headquartered in Troy, Michigan, founded in 1967, and operating as the largest and longest-standing urology group in the state. The practice delivers comprehensive urologic care through 60+ providers across 18 locations in Southeast Michigan and Grand Rapids, treating urologic cancers (prostate, bladder, kidney, testicular, penile, adrenal), men's health conditions (BPH, erectile dysfunction, low testosterone, vasectomy, Peyronie's), women's urogynecology, pediatric urology, and general urology (kidney stones, incontinence, overactive bladder).

MIU's care delivery is organized as a platform of vertically integrated specialty services. These include two ambulatory surgery centers (Michigan Surgical Utica and Town Center ASC), an Interventional Radiology Center offering prostate artery embolization and related embolization procedures, mobile PET/CT imaging units, an in-house pathology laboratory, and an ACHC-accredited In-Office Medication Dispensary for urologic medications. The practice also operates the REDEEM sexual wellness and aesthetics sub-brand in Birmingham. A long-running clinical research program (17 years, 3,000+ patients recruited, 104+ enrollments) and the Precision GU genetic testing program provide access to investigational therapies and personalized treatment selection for prostate cancer.

Commercially, MIU generates revenue through professional services billed via insurance (consultations, diagnostics, surgical and radiation procedures), facility fees from the ASCs and IR center, imaging fees from PET/CT, medication sales through the in-office dispensary, and cash-pay services at REDEEM. Patients are acquired through direct outreach via website, blog, and SEO content; community webinars and support groups (e.g., the monthly prostate cancer support group at Town Center); physician referrals; and self-referrals. Distribution is exclusively regional across Michigan, with no evidence of parent company, private equity, or venture capital ownership.

Name

Michigan Institute of Urology

Legal name

Michigan Institute of Urology, P.C.

Website

https://michiganurology.com

Company type

Private

Founded year

1967

Operating status

Operating

Headcount range

51–100 employees

Short description

Michigan Institute of Urology is an independent, physician-owned urology practice operating 60+ providers across 18 locations in Southeast Michigan and Grand Rapids, delivering comprehensive urologic cancer, men's health, women's urogynecology, and pediatric care supported by ASCs, imaging, lab, dispensary, and clinical research services.

Ownership category

akta.pro rank

Product category

Urology Healthcare Services

NAICS

Offices of Physicians (62111), Diagnostic Imaging Centers (621512)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000)

akta.pro industry

PRIMARYHLAKAOAA

General Urology

Healthcare & Life Sciences/Specialist Medical Practice/Urology

SECONDARYHLAKAOAB

Urologic Oncology

Healthcare & Life Sciences/Specialist Medical Practice/Urology

SECONDARYHLAKAOAD

Male Reproductive & Sexual Medicine (Andrology)

Healthcare & Life Sciences/Specialist Medical Practice/Urology

SECONDARYHLAKAOAC

Female Pelvic Medicine & Reconstructive Surgery (Urogynecology)

Healthcare & Life Sciences/Specialist Medical Practice/Urology

SECONDARYHLAKAOAE

Pediatric Urology

Healthcare & Life Sciences/Specialist Medical Practice/Urology

SECONDARYHLAKAOAF

Endourology & Minimally Invasive Urologic Surgery

Healthcare & Life Sciences/Specialist Medical Practice/Urology

SECONDARYHLAIACAH

Nephrology & Urology Specialty Pharmaceuticals

Healthcare & Life Sciences/Pharmaceuticals/Specialty Pharmaceuticals

Keywords

• Urology care services
• Prostate cancer treatment
• Ambulatory surgery centers
• Men's health services
• Urologic clinical research

Headquarters

HQ city

Saint Clair Shores

HQ country

United States

HQ region

North America

Offices22 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Clinical Services Revenue: Medical services revenue generated from patient consultations, diagnostic procedures, surgical interventions, and treatment services across all MIU locations including physician offices, ambulatory surgery centers, and specialty clinics.
2. In-Office Medication Dispensary: On-site pharmacy services providing erectile dysfunction medications and prostate cancer medications directly to patients, offering consistent pricing and financial assistance support.

Pricing tiers

Go-to-market motion1 record

Distribution channels6 records

Marketing channels7 records

Core offering

Michigan Institute of Urology is a physician-owned professional corporation that delivers comprehensive urologic care, including diagnosis and treatment of urologic cancers (prostate, bladder, kidney, testicular), BPH, erectile dysfunction, kidney stones, urinary incontinence, and pediatric urological conditions. The practice operates 18 locations across Southeast Michigan and Grand Rapids, supported by 60+ providers, two ambulatory surgery centers, an interventional radiology center, mobile PET/CT imaging, an on-site laboratory, an in-office medication dispensary, and a clinical research department with 17 years of trial experience.

Product overview

Michigan Institute of Urology is a healthcare practice providing urologic care across Southeast Michigan with 15+ locations. The organization operates as a platform of interconnected specialty services including advanced prostate cancer treatment, genetic testing (Precision GU), clinical trials, interventional radiology, PET/CT imaging, an on-site laboratory, and an in-office medication dispensary. REDEEM serves as a sexual wellness sub-brand. The practice offers treatment for conditions spanning cancer, kidney health, men's health, prostate health, urinary health, urogynecology, and pediatrics. Patient-facing digital services include a portal for appointments and test results.

Differentiator

Problem solved

Functional benefit

Brands

• REDEEM: Sexual wellness and aesthetics center offering treatments for sexual health, natural beauty, skin therapies, and hair growth for men and women. Located in Birmingham, Michigan.
• Precision GU

Products and services

• REDEEM Sexual Wellness A specialty clinic offering sexual wellness treatments for men and women, including vaginal rejuvenation, DUOLITH therapy for erectile dysfunction, O shots, P shots, natural beauty aesthetics, and hair restoration services.
• Interventional Radiology (IR) Center Minimally invasive treatment center offering embolization procedures for conditions including prostate artery embolization (PAE) for BPH, varicocele treatment, uterine fibroid embolization, and other vascular interventions.
• Clinical Trials Program Research program offering patients access to investigational medications and treatments for prostate cancer, bladder cancer, BPH, and other urologic conditions, with 3,000+ patients recruited and 104+ study enrollments.
• Precision GU Genetic Testing Genetic testing program offering germline and somatic testing for prostate cancer patients, providing personalized results to guide treatment decisions and inform family members about inherited cancer risks.
• PET/CT Scans for Urology Advanced imaging service providing PET/CT scans for urologic cancer detection, treatment monitoring, and treatment planning, available at mobile units in Southfield and Clinton Township.
• On-Site Laboratory In-house pathology and clinical laboratory providing urine cytology, FISH testing, tissue analysis, PSA tests, hormone level checks, blood and urine tests, and semen analysis for urologic condition diagnosis.
• In-Office Medication Dispensary ACHC-accredited dispensary providing erectile dysfunction and prostate cancer medications with private counseling, financial assistance support, and mail order options.
• Advanced Prostate Cancer Treatment Comprehensive advanced prostate cancer care including immunotherapy (PROVENGE, KEYTRUDA), targeted therapy (PLUVICTO, PARP inhibitors), hormone therapy, cryotherapy, Nanoknife, brachytherapy, and radiation therapy options.
• Patient Portal Online portal enabling patients to view test results, request prescription refills, schedule appointments, and communicate with providers through secure messaging.

Quantifiable outcome

• 3,000+ patients recruited for clinical trials
• +2 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Urologic ConsultantscoreStrategic or Co-development PartnerGrand Rapids urology practice that has joined Michigan Institute of Urology, continuing to serve existing patients at the same locations with the same providers.
• Michigan Urological CliniccoreStrategic or Co-development PartnerGrand Rapids urology practice that has joined Michigan Institute of Urology, continuing to serve existing patients at the same locations.
• Western Radiation OncologycoreTechnology or IntegrationRadiation oncology physicians collaborate with MIU for LDR Brachytherapy with Palladium-103 services at Town Center Ambulatory Surgery Center.
• CosanminorStrategic or Co-development PartnerMedicare-supported chronic care management program partnering with MIU to provide monthly telephone checkups and care coordination for patients with chronic conditions.
• Michigan Men's Health FoundationminorStrategic or Co-development PartnerNon-profit organization partnered with MIU dedicated to men's health advocacy, prostate cancer awareness, education, research, and treatment support including the Survivor Series webcast and The Blue Fund financial assistance.
• SharecareminorImplementation/ SI/ Consulting PartnerHealth data company partnered with MIU to fulfill medical records requests through their platform, providing online request processing, disability/FMLA form handling, and records status tracking.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Genesis Healthcare Partners: Multi-specialty urology and oncology platform operating multiple clinic and ASC locations with clinical research programs; closely comparable to MIU in combining physician offices, surgery centers, and clinical trials under one brand.
• Urology Austin: Large independent urology group in Central Texas with multiple clinic locations, ASC, and specialty programs including men's health and oncology — analogous to MIU in being a physician-owned multi-site urology practice with ancillaries.
• US Urology Partners: PE-backed national platform aggregating independent urology practices with multi-specialty services including oncology, clinical trials, ASCs, and imaging — directly comparable to MIU's model of an integrated, multi-site urology group with ancillaries.
• Georgia Urology: One of the largest independent urology groups in the U.S., operating multiple metro Atlanta locations with subspecialists across oncology, male reproductive medicine, and female urology — comparable to MIU in scale and comprehensive subspecialty coverage.
• Tennessee Urology Associates: Large independent urology practice with multiple clinic locations across Tennessee, providing comprehensive urologic care, oncology, and advanced treatments — directly comparable as a large multi-site independent urology group.
• Associated Medical Professionals of NY (A.M.P.): Multi-site urology group practice in New York offering general urology, urologic oncology, robotic surgery, and clinical trials across numerous offices — comparable in scale and multi-specialty structure to MIU.
• Illinois Urological Institute: Multi-site urology practice serving the Peoria/Central Illinois region with multiple physicians and offices offering general and specialty urologic care — comparable to MIU as a regional multi-location independent urology group.
• Solaris Health (Chesapeake Urology / Premier Medical Group): Large consolidated urology platform formed by combining Chesapeake Urology and others, offering comprehensive urologic care including oncology, men's health, clinical trials, and ambulatory surgery — a direct analog to MIU's integrated practice model.

Others

• U.S. Anesthesia Partners (USAP): PE-backed specialty-physician platform aggregator — not a urology peer, but a comparable independent physician-group consolidation model used by MIU's competitors and useful as a structural comp for PE-driven specialty roll-ups.

Broad incumbents

• Corewell Health (Beaumont Health): Large Michigan-based health system whose hospitals (including Beaumont Troy and Dearborn) partner with MIU physicians for urology services — a broad incumbent in MIU's core geography and a key referral/partner relationship.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Subsidiaries7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Michigan Institute of Urology